Browsing by Author "Teixeira, Helena M."
Now showing 1 - 5 of 5
Results Per Page
Sort Options
- An improved analytical strategy combining microextraction by packed sorbent combined with ultra high pressure liquid chromatography for the determination of fluoxetine, clomipramine and their active metabolites in human urinePublication . Alves, Vera; Gonçalves, João; Conceição, Carlota; Teixeira, Helena M.; Câmara, José S.A powerful and sensitive method, by microextraction packed sorbent (MEPS), and ultra-high performance liquid chromatography (UHPLC) with a photodiode array (PDA) detection, is described for the determination of fluoxetine, clomipramine and their active metabolites in human urine samples. The MEPS variables, such as sample volume, pH, number of extraction cycles (draw-eject), and desorption conditions (solvent and solvent volume of elution) were optimized. The analysis were carried out using small sample volumes (500μL) and in a short time period (5min for the entire sample preparation step). Good linearity was obtained for all antidepressants with the correlation coefficients (R(2)) above 0.9965. The limits of detection (LOD) ranged from 0.068 to 0.087μgmL(-1). The recoveries were from 93% to 98%, with relative standard deviations less than 6%. The inter-day precision, expressed as the relative standard deviation, varied between 3.8% and 8.5% while the intra-day precision between 3.0% and 7.1%. In order to evaluate the proposed method for clinical use, the MEPS/UHPLC-PDA method was applied to analysis of urine samples from depressed patients.
- Development of MEPS–UHPLC/PDA methodology for the quantification of clozapine, risperidone and their major active metabolites in human urinePublication . Gonçalves, João L.; Alves, Vera L.; Conceição, Carlota J.F.; Teixeira, Helena M.; Câmara, José S.A new, fast and reliable methodology using a digitally controlled microextraction by packed sorbent (MEPS), followed by ultrahigh pressure liquid chromatography (UHPLC) separation combined with a photodiode array (PDA) detection, has been developed and validated for the simultaneous determination of clozapine and risperidone, and their active metabolites, in urine samples. Important parameters affecting MEPS performance, including type of sorbent material (C2, C8, C18, SIL, M1, R-AX, R-CX, PGC, PEP, HLB-DVB and H-DVB), elution solvent system, number of extraction cycles, sample volume, elution volume, and sample pH, were evaluated. The optimal experimental conditions involved the loading of 500 μl of sample through a C18 sorbent in a five extraction cycles and in a short time period (5 min for the entire sample preparation step). The obtained extract was analyzed by UHPLC, using a binary mobile phase, composed of aqueous 0.1% formic acid and methanol in the gradient elution mode (10 min total analysis). Good results were obtained under the optimized conditions, in terms of linearity with correlation coefficients (r2) values higher than 0.9986. Low detection limits, ranging between 0.052 and 0.055 μg ml− 1 were achieved, whereas the lowest quantification limit was 0.1 μg ml− 1, corresponding to the lowest concentration of the standard curve. Satisfactory results were found with accuracy values ranging from 83% to 116%, and with precision results from 2.65% to 18%. Recoveries ranged between 76% and 96%, which was in agreement with results reported by other studies.
- Improved analytical approach based on QuECHERS/UHPLC-PDA for quantification of fluoxetine, clomipramine and their active metabolites in human urine samplesPublication . Alves, Vera; Conceição, Carlota; Gonçalves, João; Teixeira, Helena M.; Câmara, JoséThis paper reports, for the first time, the development of a modified Quick, Easy, Cheap Effective, Rugged and Safe (QuEChERS) combined with a dispersive SPE (d-SPE) based clean-up procedure as a new and powerful strategy for the simultaneous and efficient isolation of two different antidepressants, fluoxetine and clomipramine, and their active metabolites in human urine samples. A univariate experimental design with four independent variables such as sample volume, extraction solvent, buffered salts and clean-up step, was performed and used to investigate the effect of process variables on the extraction efficiency. Good linearity was achieved at the studied concentration range (0.1-5.0 µg mL-1), with correlation coefficients (R2) higher than 0.9961. Low detection limits, ranging between 0.060 and 0.092 μg mL-1 were obtained for all analytes, whereas the lowest quantification limit was 0.1 μg mL-1, corresponding to the lowest concentration of the standard curve. The method also showed good results for accuracy, with values ranging from 91% to 105%. Intra- and inter-day precision, expressed as the relative standard deviation (RSD), were also satisfactory (<10%). Consistent recoveries of antidepressants ranging from 86% to 109% were observed when urine samples were fortified at three concentrations, namely 0.1, 2.5 and 5.0 μg mL-1 In order to evaluate the proposed method for clinical use, the QuEChERS/UHPLC-PDA method was applied to analysis of 12 urine samples from depressed patients.
- Structure assignment of seized products containing cathinone derivatives using high resolution analytical techniquesPublication . Gonçalves, João L.; Alves, Vera L.; Aguiar, Joselin; Caldeira, Maria J.; Teixeira, Helena M.; Câmara, José S.The innovation of the new psychoactive substances (NPS) market requires the rapid identification of new substances that can be a risk to public health, in order to reduce the damage from their use. Twelve seized products suspected to contain illicit substances were analyzed by attenuated total reflectance Fourier transform infrared spectroscopy (ATR-FTIR), gas chromatography coupled to mass spectrometry (GC-MS), and nuclear magnetic resonance spectroscopy (NMR). Synthetic cathinones (SCat) were found in all products, either as a single component or in mixtures. Infrared spectra of all products were consistent with the molecular structure of SCat, showing an intense absorption band at 1700–1674 cm−1 , corresponding to the carbonyl stretching, a medium/strong peak at 1605–1580 cm−1 , indicating stretching vibrations in the aromatic ring (C=C) and bands with relative low intensity at frequencies near 2700–2400 cm−1 , corresponding to an amine salt. It was possible to identify a total of eight cathinone derivatives by GC-MS and NMR analysis: 40 -methyl-α pyrrolidinohexanophenone (MPHP), α-pyrrolidinohexanophenone (α-PHP), 3-fluoromethcathinone (3-FMC), methedrone, methylone, buphedrone, N-ethylcathinone, and pentedrone. Among the adulterants found in these samples, caffeine was the most frequently detected substance, followed by ethylphenidate. These results highlight the prevalence of SCat in seized materials of the Portuguese market. Reference standards are usually required for confirmation, but when reference materials are not available, the combination of complementary techniques is fundamental for a rapid and an unequivocal identification of such substances.
- The synthetic cannabinoids phenomenon: from structure to toxicological properties. A reviewPublication . Alves, Vera L.; Gonçalves, João L.; Aguiar, Joselin; Teixeira, Helena M.; Câmara, José S.The word “cannabinoid” refers to every chemical substance, regardless of structure or origin, that joins the cannabinoid receptors of the body and brain and that have similar effects to those produced by the Cannabis plant and based on their source of production, cannabinoids can be classified into endocannabinoids, phytocannabinoids and synthetic cannabinoids. Synthetic cannabinoids represent the largest class of drugs detected through the EU Early Warning System with a total of 190 substances notified from 2008 to 2018 and about 280 have been reported worldwide to the United Nations Office on Drugs and Crime. Sprayed on natural herb mixtures with the aim to mimic the euphoria effect of cannabis and sold as “herbal smoking blends” or “herbal incense” under brand names like “Spice” or “K2”, synthetic cannabinoids are available from websites for the combination with herbal materials or more recently, for the use in e-cigarettes. Currently labeled as “not for human consumption” to circum vent legislation, their legal status varies by country with many government institutions currently push ing for their control. However, due to the emergence of new substances, it requires a constant update of the list of controlled drugs. Little is known about how these substances work and their toxic effects in humans and the same product could vary not only in the amount and in the type of substance added. In the last years, synthetic cannabinoids have been associated with deaths and acute intoxica tions in Europe and, despite a range of new measures introduced in this area, continue to represent a challenge to current drug policy models. These synthetic substances are much more potent than nat ural cannabis, as well as displayed greater efficacy, acting as full agonists at the cannabinoid receptors. It is possible that, along with being highly potent, some may also have long half-lives, potentially lead ing to a prolonged psychoactive effect. The present work provides a review on existing literature about the development of synthetic cannabinoids as substances of abuse, current patterns of abuse and their legal status, chemical classification, and some pharmacological and toxicological properties.